The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT trial.
 
Katja Weisel
Honoraria - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Amgen (Inst); Celgene (Inst); Janssen (Inst); Sanofi (Inst)
 
Anne Marie Asemissen
Consulting or Advisory Role - Pfizer
Research Funding - Celgene
 
Britta Besemer
Honoraria - Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag
 
Mathias Haenel
Honoraria - Novartis; Roche
Consulting or Advisory Role - Amgen; Celgene; Sanofi; Takeda
 
Igor W. Blau
No Relationships to Disclose
 
Martin Goerner
No Relationships to Disclose
 
Yon-Dschun Ko
No Relationships to Disclose
 
Jan Dürig
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
Travel, Accommodations, Expenses - Celgene; Janssen
 
Peter Staib
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen-Cilag
Speakers' Bureau - Abbvie; Amgen; Celgene
Research Funding - Abbvie; Celgene; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Celgene; Gilead Sciences; Pfizer; Roche
 
Christoph Mann
No Relationships to Disclose
 
Raphael Lutz
No Relationships to Disclose
 
Markus Munder
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi
Research Funding - Bristol-Myers Squibb; Incyte
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen; Takeda
 
Ullrich Graeven
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Hexal; Johnson & Johnson; Merck KGaA; MSD Oncology
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Merck KGaA
 
Rudolph Peceny
No Relationships to Disclose
 
Hans Salwender
No Relationships to Disclose
 
Manola Zago
No Relationships to Disclose
 
Axel Benner
Travel, Accommodations, Expenses - Sanofi
 
Diana Tichy
No Relationships to Disclose
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Roche; Sanofi
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; GSO; Lilly/ImClone; Merck Serono; Merck Sharp & Dohme; Sanofi
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Agile Therapeutics (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); Apellis Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BerGenBio (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Glycotope GmbH (Inst); Incyte (Inst); iOMEDICO (Inst); Isofol Medical (Inst); Janssen-Cilag (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Millennium (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Springworks Therapeutics (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pfizer; Sanofi
 
Hartmut Goldschmidt
Honoraria - Art tempi; Bristol-Myers Squibb; Celgene; Chugai Pharma; Janssen-Cilag; Novartis; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Molecular Partners (Inst); MSD (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda